Literature DB >> 30578115

Primary Care Physician Attitudes and Intentions Toward the Use of HIV Pre-exposure Prophylaxis in Adolescents in One Metropolitan Region.

Tanya L Kowalczyk Mullins1, Caitlyn R Idoine2, Gregory D Zimet3, Jessica A Kahn4.   

Abstract

PURPOSE: Understanding the attitudes of physicians toward the use of pre-exposure prophylaxis (PrEP) for HIV prevention among youth is critical to improving access to PrEP. We examined PrEP-related attitudes among physicians who provide primary care to 13- to 21-year-old adolescents.
METHODS: Individual, in-depth, semistructured interviews were conducted with 38 physicians from adolescent medicine, family practice, internal medicine/medicine-pediatrics, obstetrics/gynecology, and pediatrics who care for any adolescents younger than 18 years. Interviews assessed familiarity with PrEP, perceived benefits and barriers to providing PrEP to adolescents, facilitating factors for prescribing PrEP, and likelihood of recommending and prescribing PrEP to adolescents.
RESULTS: Mean age was 44.6 years (standard deviation 10.9). Fourteen physicians (37%) reported being somewhat or very familiar with PrEP. Perceived benefits of prescribing PrEP included decreased acquisition/rates of HIV, improved provision of sexual health services, and improved patient awareness of HIV risk. Barriers to PrEP were reported at the patient (e.g., lack of acceptability to patients), provider (e.g., concerns about patient adherence, safety/side effects, parents as a barrier to PrEP use), and system (e.g., high cost) levels. Facilitating factors for prescribing PrEP included low cost/coverage by insurance, physician education about PrEP, patient educational materials, and clinical guidelines for PrEP use in youth. A higher proportion of physicians reported being highly or somewhat likely to recommend (N = 16, 42%) than prescribe PrEP (N = 13, 34%).
CONCLUSIONS: In this study of primary care physician attitudes toward PrEP prescribing for adolescents, physicians identified numerous barriers to providing PrEP. Addressing these barriers may increase adolescents' access to PrEP.
Copyright © 2018 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescent; HIV; Physicians; Prevention; Prophylaxis

Mesh:

Year:  2018        PMID: 30578115      PMCID: PMC6478546          DOI: 10.1016/j.jadohealth.2018.10.300

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  32 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

Review 2.  State adolescent consent laws and implications for HIV pre-exposure prophylaxis.

Authors:  Lindsay Culp; Lisa Caucci
Journal:  Am J Prev Med       Date:  2013-01       Impact factor: 5.043

3.  Forgone health care among U.S. adolescents: associations between risk characteristics and confidentiality concern.

Authors:  Jocelyn A Lehrer; Robert Pantell; Kathleen Tebb; Mary-Ann Shafer
Journal:  J Adolesc Health       Date:  2006-12-14       Impact factor: 5.012

4.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

5.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

6.  Utilization of health services in physician offices and outpatient clinics by adolescents and young women in the United States: implications for improving access to reproductive health services.

Authors:  Karen W Hoover; Guoyu Tao; Stuart Berman; Charlotte K Kent
Journal:  J Adolesc Health       Date:  2009-11-24       Impact factor: 5.012

7.  Effect of mandatory parental notification on adolescent girls' use of sexual health care services.

Authors:  Diane M Reddy; Raymond Fleming; Carolyne Swain
Journal:  JAMA       Date:  2002-08-14       Impact factor: 56.272

8.  Pharmacists' attitudes toward and practices with adolescents.

Authors:  Lee Ann E Conard; J Dennis Fortenberry; Margaret J Blythe; Donald P Orr
Journal:  Arch Pediatr Adolesc Med       Date:  2003-04

9.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Authors:  Kachit Choopanya; Michael Martin; Pravan Suntharasamai; Udomsak Sangkum; Philip A Mock; Manoj Leethochawalit; Sithisat Chiamwongpaet; Praphan Kitisin; Pitinan Natrujirote; Somyot Kittimunkong; Rutt Chuachoowong; Roman J Gvetadze; Janet M McNicholl; Lynn A Paxton; Marcel E Curlin; Craig W Hendrix; Suphak Vanichseni
Journal:  Lancet       Date:  2013-06-13       Impact factor: 79.321

10.  A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection.

Authors:  Emily A Arnold; Patrick Hazelton; Tim Lane; Katerina A Christopoulos; Gabriel R Galindo; Wayne T Steward; Stephen F Morin
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

View more
  7 in total

1.  Pediatric Provider Utilization of a Clinical Decision Support Alert and Association with HIV Pre-exposure Prophylaxis Prescription Rates.

Authors:  Carrie T Chan; Megen Vo; Jennifer Carlson; Tzielan Lee; Marcello Chang; Geoffrey Hart-Cooper
Journal:  Appl Clin Inform       Date:  2022-01-12       Impact factor: 2.342

2.  Health Care Providers' Views on Clinic Infrastructure and Practice Models That May Facilitate HIV Preexposure Prophylaxis (PrEP) Prescribing: A Qualitative Meta-Synthesis.

Authors:  Yuko Mizuno; Deborah J Gelaude; Nicole Crepaz; Emiko Kamitani; Julia B DeLuca; Carolyn A Leighton; Megan E Wichser; Dawn K Smith
Journal:  Health Promot Pract       Date:  2021-09-22

3.  Provider Comfort with Prescribing HIV Pre-Exposure Prophylaxis to Adolescents.

Authors:  Paulo Pina; Tamara Taggart; Miguel Sanchez Acosta; Ivie Eweka; Miguel Muñoz-Laboy; Tashuna Albritton
Journal:  AIDS Patient Care STDS       Date:  2021-10       Impact factor: 5.944

4.  Scaling up PrEP for Women: What We Can Learn From Title X Clinics in the Southern United States.

Authors:  Jack Rusley; Alison Riese
Journal:  J Adolesc Health       Date:  2021-03       Impact factor: 5.012

5.  Awareness and Knowledge of Pre-exposure Prophylaxis Among Sexual and Gender Minority Adolescents Assigned Male at Birth in the United States.

Authors:  Margaret Matson; Mara Nery-Hurwit; Shariell Crosby; George J Greene; Kathryn Macapagal
Journal:  Arch Sex Behav       Date:  2021-05-12

Review 6.  Getting youth PrEPared: adolescent consent laws and implications for the availability of PrEP among youth in countries outside of the United States.

Authors:  Tamara Taggart; Keosha T Bond; Tiarney D Ritchwood; Justin C Smith
Journal:  J Int AIDS Soc       Date:  2019-07       Impact factor: 5.396

Review 7.  Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review.

Authors:  Kenneth H Mayer; Allison Agwu; David Malebranche
Journal:  Adv Ther       Date:  2020-03-30       Impact factor: 3.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.